Bleeding Control
-
Study finds pixaban (Eliquis) is preferable to rivaroxaban (Xarelto) for stroke prevention, reduced bleeding complications
There is strong evidence that the medication apixaban (Eliquis) is preferable to rivaroxaban (Xarelto) for stoke prevention in patients with atrial fibrillation (AF), with both reduced rates of severe bleeding complications as well as strokes, according to study published Dec. 21 in JAMA. Read MoreDec 21, 2021
-
VUMC offering public courses on how to control bleeding
Vanderbilt University Medical Center is providing bleeding control training courses across the region in an effort to educate the public on what they can do in an emergency to potentially save a life. Read MoreMar 22, 2018